Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Convertible Debt (2016 - 2025)

Historic Convertible Debt for Ironwood Pharmaceuticals (IRWD) over the last 11 years, with Q1 2025 value amounting to $199.2 million.

  • Ironwood Pharmaceuticals' Convertible Debt rose 34.41% to $199.2 million in Q1 2025 from the same period last year, while for Mar 2025 it was $199.2 million, marking a year-over-year increase of 34.41%. This contributed to the annual value of $199.0 million for FY2024, which is 34.24% up from last year.
  • As of Q1 2025, Ironwood Pharmaceuticals' Convertible Debt stood at $199.2 million, which was up 34.41% from $199.0 million recorded in Q4 2024.
  • In the past 5 years, Ironwood Pharmaceuticals' Convertible Debt ranged from a high of $436.1 million in Q1 2021 and a low of $198.0 million during Q2 2023
  • In the last 5 years, Ironwood Pharmaceuticals' Convertible Debt had a median value of $329.2 million in 2021 and averaged $294.3 million.
  • Its Convertible Debt has fluctuated over the past 5 years, first soared by 2014.13% in 2022, then plummeted by 4996.21% in 2024.
  • Over the past 5 years, Ironwood Pharmaceuticals' Convertible Debt (Quarter) stood at $337.3 million in 2021, then rose by 17.47% to $396.3 million in 2022, then tumbled by 49.95% to $198.3 million in 2023, then increased by 0.34% to $199.0 million in 2024, then increased by 0.09% to $199.2 million in 2025.
  • Its Convertible Debt was $199.2 million in Q1 2025, compared to $199.0 million in Q4 2024 and $198.8 million in Q3 2024.